Drawing for ISEMBYLD

USPTO serial 97723538

ISEMBYLD

Reviewed by CopyMark Law Group

Status 819
Filing date
Status date
Registration date
—
Examiner
FEDERICO, EVAN G
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ISEMBYLD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas R. Wolf

Douglas R. Wolf WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
005Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disordersACTIVEOct 20, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 2, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 2, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 21, 2026IUAFUSE AMENDMENT FILED—
Oct 21, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 7, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 7, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 7, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 3, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 3, 2026EX5GSOU EXTENSION 5 GRANTED—
May 7, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2026EXT5SOU EXTENSION 5 FILED—
Dec 5, 2025IULNITU LETTER MAILED, NO RESPONSE REQUIRED—
Nov 18, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 29, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 28, 2025EX4GSOU EXTENSION 4 GRANTED—
Oct 28, 2025EXT4SOU EXTENSION 4 FILED—
Oct 28, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 28, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2025EX3GSOU EXTENSION 3 GRANTED—
Jan 29, 2025EXT3SOU EXTENSION 3 FILED—
Jan 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 25, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 25, 2024EX2GSOU EXTENSION 2 GRANTED—
Oct 25, 2024EXT2SOU EXTENSION 2 FILED—
Oct 25, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 9, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 8, 2024EX1GSOU EXTENSION 1 GRANTED—
Mar 8, 2024EXT1SOU EXTENSION 1 FILED—
Mar 8, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 26, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 25, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Sep 25, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 25, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 25, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 20, 2023DOCKASSIGNED TO EXAMINER—
Dec 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance